buprenorphine hydrochloride and naloxone hydrochloride
buprenorphine hydrochloride and naloxone hydrochloride is listed in the FDA National Drug Code directory with 16 NDC codes, marketed under brand names including Zubsolv, Buprenorphine and Naloxone. Available dosage forms: tablet, orally disintegrating, tablet.
Drug details
- Generic Name
- buprenorphine hydrochloride and naloxone hydrochloride
- Brand Names
- Zubsolv, Buprenorphine and Naloxone
- Application Number
- NDA204242
- Sponsor
- Orexo US, Inc.
- NDC Codes
- 16
- Dosage Forms
- TABLET, ORALLY DISINTEGRATING, TABLET
- Routes
- SUBLINGUAL
- Active Ingredients
- BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE ZUBSOLV is indicated for treatment of opioid dependence. ZUBSOLV should be used as part of a complete treatment plan that includes counseling and psychosocial support. ZUBSOLV contains buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist, and is indicated for treatment of opioid dependence. ( 1 ) ZUBSOLV should be used as part of a complete treatment plan that includes counseling and psychosocial support. ( 1 )